Amado Cavazos - Innophos Holdings Independent Director

Director

Mr. Amado Cavazos is the Independent Director of Innophos Holdings Inc., since 2008. Mr. Cavazos retired from Du Pont, S.A. de C.V. in 2003 after holding numerous management and executive positions in Mexico, Venezuela, Puerto Rico and USA since 1968. From 1996 to 2003, Mr. Cavazos was Director of Coatings Businesses for Mexico and Central America. He was Group Director of Du Pont Mexico from 1993 to 1995 and Director of Corporationrationrate Planning from 1989 to 1993. During this time he represented Du Pont on several Boards of Directors Nylon de Mexico, Tetraetilo de Mexico, Qumica Fluor, and Industrias Tecnos. From 1982 to 1987, Mr. Cavazos was Group Director for Du Pont Mexico and COO for three of its joint ventures, reporting directly to the Boards of Directors since 2008.
Age 69
Tenure 16 years
Professional MarksMBA
Phone609 495-2495
Webwww.innophos.com
Cavazos earned a B.S. in Chemical Engineering from Virginia Polytechnic Institute and an M.B.A. from Tecnológico de Monterrey. He served as member of the executive committee 19901999 and Chairman 19992001 of ANIQ, the chemical manufacturers association of Mexico.

Innophos Holdings Management Efficiency

Innophos Holdings' management efficiency ratios could be used to measure how well Innophos Holdings manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 399.86 M in liabilities with Debt to Equity (D/E) ratio of 118.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Innophos Holdings has a current ratio of 2.88, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Innophos Holdings until it has trouble settling it off, either with new capital or with free cash flow. So, Innophos Holdings' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Innophos Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Innophos to invest in growth at high rates of return. When we think about Innophos Holdings' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

George BuckleyPepsiCo
71
Clarence CazalotSea
64
Shona BrownPepsiCo
52
William JohnsonPepsiCo
69
Craig SmithWillamette Valley Vineyards
67
Alberto IbarguenPepsiCo
70
Miranda HubbsSea
48
Dina DublonPepsiCo
65
Robert PohladPepsiCo
63
Hou TianyuSea
46
Yuxin RenSea
43
Michelle GassPepsiCo
50
Anthony ComperSea
69
Cesar CondePepsiCo
44
Richard FisherPepsiCo
69
Rona FairheadPepsiCo
54
Heather WestingWillamette Valley Vineyards
N/A
Tianyu HouSea
46
Lloyd TrotterPepsiCo
69
Agnieszka GrzeszczakPepsiCo
N/A
Gregory DavisZevia Pbc
N/A
Innophos Holdings, Inc., together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. As of February 7, 2020, Innophos Holdings, Inc. operates as a subsidiary of Iris Parent LLC. Innophos Holdings operates under Specialty Chemicals classification in USA and is traded on NASDAQ. It employs 1485 people. Innophos Holdings (IPHS) is traded on NASDAQ Exchange in USA and employs 1,485 people.

Management Performance

Innophos Holdings Leadership Team

Elected by the shareholders, the Innophos Holdings' board of directors comprises two types of representatives: Innophos Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Innophos. The board's role is to monitor Innophos Holdings' management team and ensure that shareholders' interests are well served. Innophos Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Innophos Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
Randolph Gress, Chairman, CEO and Pres
Eugenia Erlij, Vice President - Marketing
Kim Mink, CEO and President and Director
Abraham Shabot, Vice President Director General, Innophos Latin America
James Zallie, Independent Director
Peter Thomas, Director
Jean Mainente, Chief Human Resource Officer, Senior Vice President
William Dunworth, Chief Accounting Officer, Vice President Corporate Controller
Amado Cavazos, Independent Director
Nicolas Meyrial, Vice President - Commercial Nutrition
William Farran, Sr. VP, General Counsel and Member of Proxy Committee
Mark Thurston, Vice President - Corporate Strategy and Worldwide Business Development
Mark Feuerbach, Sr. VP of Investor Relations, Treasury, Financial Planning and Analysis
Mark Santangelo, Senior Vice President - Manufacturing, Engineering and EH&S
Gary Cappeline, Lead Independent Director
Susan Turner, Vice President - Quality & Regulatory
Yasef Murat, Senior Vice President - Global Manufacturing
Hermanus Kieftenbeld, CFO, Senior Vice President
Linda Myrick, Independent Director
Amy Hartzell, Vice President - Supply Chain and Purchasing
Sherry Duff, Chief Marketing Officer, Vice President
Gail Holler, Vice President - Human Resources
Joshua Horenstein, Acting Chief Legal Officer and Corporate Secretary
Jane Hilk, Director
Louis Calvarin, Chief Risk Officer and Sr. VP of Strategy
Robert Sklans, Chief Human Resource Officer, Senior Vice President
Joseph Golowski, Sr. VP of Global Specialty Phosphates
Charles Brodheim, Vice President Corporate Controller
Karen Osar, Independent Director
John Steitz, Independent Director
Robert Zatta, Director

Innophos Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Innophos Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
Note that the Innophos Holdings information on this page should be used as a complementary analysis to other Innophos Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Consideration for investing in Innophos Stock

If you are still planning to invest in Innophos Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Innophos Holdings' history and understand the potential risks before investing.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios